Close

Inflammation

Famotidine Aids in COVID-19 by Helping Limit Inflammation

Researchers have discovered just how the antacid famotidine, commonly sold as Pepcid by a Johnson & Johnson unit, was able to help alleviate COVID-19 symptoms in clinical trials. In studies in mice, they found that famotidine stimulates the vagus nerve, which controls the immune system and other involuntary body functions. […]

Read More

Study: Inflammation, not the virus itself, causes COVID-19-related loss of smell

Anosmia, the loss of smell, is a frequent and often long-term symptom associated with COVID-19 that can severely burden a person’s quality of life, making it extremely difficult to taste foods, detect airborne hazards in the environment, and carry out other functions dependent on the sense. While the devastating impacts […]

Read More

Beta-Blocker Reduces Lung Inflammation in Critical COVID-19

In a small study, intravenous administration of the beta-blocker metoprolol to critically ill COVID-19 patients with acute respiratory distress syndrome (ARDS) safely blunted lung inflammation associated with the disease. Metoprolol administration also resulted in better oxygenation and fewer days on intensive mechanical ventilation (IMV) and in the intensive care unit (ICU), compared with no treatment. These […]

Read More

Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients

Background and Purpose: Reports indicate an increased risk of ischemic stroke during coronavirus disease 2019 (COVID-19) infection. We aimed to identify patients with COVID-19 and ischemic stroke and explore markers of inflammation, hypercoagulability, and endotheliopathy, a structural and functional disturbance of the vascular endothelium due to a stressor. Methods: This […]

Read More
Translate »